This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.

Personal Injury (Non-Vehicular)
Pharmaceutical Malpractice

Young v. Key Pharmaceutical

Published: May 25, 1993 | Result Date: Apr. 30, 1993 | Filing Date: Jan. 1, 1900 |

Case number: 862106413 Verdict –  $0

Judge

Charles Mertel

Court

Kings Superior


Attorneys

Plaintiff

Bonnie Bakeman Harrison

John P. Walsh

James L. Holman

Joel D. Cunningham

Emmet Walsh


Defendant

John G. Fritts

Michael Garnier

Jean Pierre Garnier


Experts

Plaintiff

Gregory Redding
(medical)

Jerome Klein
(medical)

Jerrold Milstein
(medical)

Kenneth Renton
(medical)

John T. Chapman
(medical)

Judy Matas
(technical)

Leslie Hendeles
(medical)

Frederick Hull Hayes
(medical)

Olga A. Woo Jr.
(medical)

Carole Shiel
(medical)

Jack Dahlberg
(technical)

Lowell Bassett
(technical)

Gideon Koren
(medical)

Michael Krebs
(medical)

Ronald Case
(medical)

Morris Horning
(medical)

Allyn Golub
(technical)

James Degel
(technical)

Forrest C. Bennett
(medical)

Defendant

Frederick Braun
(medical)

Kuo Chang
(medical)

Thomas A. Campbell
(medical)

Richard D. Carroll
(Kelly Trotter & Franzen) (technical)

Facts

Plaintiff E. Rosa Young, a 3 1/2-year-old asthmatic male child, suffered brain damage following prolonged seizures which occurred at 3:00 a.m., February 1, 1979. During the 18-month period preceding his injury, Plaintiff had presented to the emergency room 83 times, and had been hospitalized four times for life threatening asthma. During this period, Plaintiff had been taking various forms of theophylline to control asthma. For a 5-month period prior to his injury, Plaintiff had been taking Theo-Dur, a sustained release form of theophylline. Theo-Dur is manufactured by Defendant Key Pharmaceuticals. Therapeutic levels of theophylline are considered to be between 10 and 20 mc/ml with levels below 10 mc/ml considered sub-therapeutic and levels above 20 mc/ml considered toxic. Upon admission to the emergency room, Plaintiff's theophylline level was found to be 68 mc/ml.

Settlement Discussions

A 2-day mediation by Jack Rosenow of Seattle was held during trial. Plaintiff demanded $8,800,000 in cash with an additional annuity in the amount of $1,500,000 ($13,000,000 lifetime payout). Plaintiffs terminated the mediation upon receipt of Defendant's offer. Defendants offered $1,850,000 ($350,000 cash; $1,500,000 structure with lifetime payout of $13,000,000).

Damages

$9,100,000 in speical damages to include lost earnings, medical care services, medical commodities, attendant care, et cetera. Plaintiff asked the jury to make an unspecified additonal award for general damages. Defendant asked the jury for a defense verdict. Defendant presented testimony as to the present value of future payments which could be made assuming the purchase of a $2,000,000 annuity. Total lifetime payout would have exceeded $26,000,000.

Injuries

Dramatic neurodevelopmental regression following prolonged seizures and anoxic encephalopathy; current gross motor skills at age 18 years of age is in the range of a 2.5 year old and fine motor skills in the range of an 18 month old; current receptive abilities have been evaluated in the 20-24 month range with expressive skills in the 12-month range; current diagnosis is permanent and severe mental retardation with severe communicative disfunction and autistic behavioral features.

Deliberation

4 days

Poll

10-2

Length

6 weeks


#98781

For reprint rights or to order a copy of your photo:

Email jeremy@reprintpros.com for prices.
Direct dial: 949-702-5390